Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Johnson & Johnson lifts guidance on strong Q2 sales, shares pop

(Sharecast News) - US healthcare company Johnson & Johnson raised on Wednesday annual earnings and sales guidance on the back of strong sales and foreign exchange tailwinds, sending shares in the firm up 5.5%. The drug and medical equipment maker posted a rise in second-quarter sales to $23.7bn year-on-year, beating the $22.8bn forecast by analysts. Earnings per share came in at $2.77 compared with estimates of $2.68.

Adjusted sales growth for the full year was now expected to be 3.2 - 3.7%, up from 2-3%. J&J now expects full-year sales, including the impact of foreign currency, in the range of $93.2bn - $93.6bn, up from an April forecast of $91bn - $91.8bn when the company said it was $400m in costs related to tariffs.

Reporting by Frank Prenesti for Sharecast.com

Share this article

Related Sharecast Articles

PE firm Arcline not planning to bid for Senior
(Sharecast News) - Private equity firm Arcline Investment Management said on Wednesday that it does not intend to make an offer for engineer Senior.
JPMorgan American Investment Trust reports positive but lagging performance
(Sharecast News) - JPMorgan American Investment Trust reported a positive but lagging performance in 2025 on Wednesday, as its quality-focused investment approach underperformed a market driven by higher-risk stocks, while the board struck an optimistic tone on the outlook for US equities.
Topps Tiles to shut 23 stores in cost-saving bid
(Sharecast News) - Topps Tiles announced plans to shut 23 underperforming stores on Wednesday as the tile specialist looks to save costs.
Berenberg downgrades Future to 'hold', slashes target price
(Sharecast News) -

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.